Palvella Therapeutics (PVLA) EBITDA Margin Growth (1y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -446,112.00 |
| Sep 30, 2023 | 374,243.00 |
| Jun 30, 2023 | 32,882.00 |
| Mar 31, 2023 | -64,453.00 |
| Sep 30, 2022 | -323,234.00 |
| Jun 30, 2022 | 30,103.00 |
| Mar 31, 2022 | -1,696.00 |
| Dec 31, 2021 | 55,354.00 |
| Sep 30, 2021 | -10,407.00 |
| Jun 30, 2021 | -56,602.00 |
| Mar 31, 2021 | -700.00 |
| Dec 31, 2020 | -67,353.00 |
| Sep 30, 2020 | -47,254.00 |
| Jun 30, 2020 | 19,016.00 |
| Mar 31, 2020 | 8,893.00 |
| Dec 31, 2019 | 186,746.00 |
| Sep 30, 2019 | 7,563.00 |
| Jun 30, 2019 | -26,006.00 |
| Mar 31, 2019 | 13,039.00 |
| Dec 31, 2018 | -196,427.00 |
| Sep 30, 2018 | 11,034.00 |
| Jun 30, 2018 | 60,624.00 |
| Mar 31, 2018 | 35,078.00 |
| Dec 31, 2017 | 26,402.00 |
| Sep 30, 2017 | 59,718.00 |
| Jun 30, 2017 | -3,871.00 |
| Mar 31, 2017 | -24,004.00 |
| Dec 31, 2016 | -84,100.00 |
| Sep 30, 2016 | 14,880.00 |
| Jun 30, 2016 | 166,547.00 |
| Mar 31, 2016 | 134,942.00 |
| Sep 30, 2015 | 889,701.00 |
| Jun 30, 2015 | -180,895.00 |